Assessing the test–retest repeatability of insulin resistance measures: Homeostasis model assessment 2 and oral glucose insulin sensitivity
Journal of Metabolic Health · 2017
DOI: 10.4102/jir.v2i1.27 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Metabolic Health, 2017. Verfasst von Catherine A.P. Crofts und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Insulin resistance is commonly assessed using the homeostasis model assessment (HOMA) variants. HOMA is potentially insensitive to change because of its high coefficient of variation. The repeatability coefficient is an alternative means of assessing test repeatability. To be confident of clinical change, rather than biological variation, a subsequent test needs to differ from the former by more than the repeatability coefficient using the equation.Test 1 = Test 2 ± repeatability coefficient.The repeatability coefficients for measures of insulin resistance are unknown.
Aim
To compare the repeatability coefficient of HOMA2 variants (Beta-cell function [%B], insulin sensitivity [%S], insulin resistance [IR]) to a dynamic measure of insulin resistance, and the oral glucose insulin sensitivity (OGIS) test.
Setting
The raw data from a previously used data set were reanalysed.
Methods
Glycaemic and insulinaemic tests were performed on 32 men and women both with (n = 10) and without type 2 diabetes (n = 22). From these data, eight fasting tests and three 50-g oral glucose tolerance tests were used to calculate HOMA2 and OGIS. The methods of Bland and Altman assessed repeatability.
Results
Repeatability coefficients for all participants for the HOMA2 %B, %S and IR variants were 72.91, 189.75 and 0.9, which equates to 89%, 135% and 89% of their respective grand means. By contrast, OGIS had a repeatability coefficient of 87.13, which equates to 21% of the grand mean.
Conclusion
Because of the high repeatability coefficient relative to the grand mean, use of HOMA2 measures for assessing insulin resistance in small population studies should be reconsidered.
Zitieren
APA
Crofts, C. A., Wheldon, M. C., Zinn, C., Lan-Pidhainy, X., Wolever, T. M., & Schofield, G. (2017). Assessing the test–retest repeatability of insulin resistance measures: Homeostasis model assessment 2 and oral glucose insulin sensitivity. Journal of Metabolic Health. https://doi.org/10.4102/jir.v2i1.27
Vancouver
Crofts CA, Wheldon MC, Zinn C, Lan-Pidhainy X, Wolever TM, Schofield G. Assessing the test–retest repeatability of insulin resistance measures: Homeostasis model assessment 2 and oral glucose insulin sensitivity. Journal of Metabolic Health. 2017. doi:10.4102/jir.v2i1.27
BibTeX
@article{Crofts2017,
author = {Crofts, Catherine A.P. and Wheldon, Mark C. and Zinn, Caryn and Lan-Pidhainy, Xiaomiao and Wolever, Thomas M.S. and Schofield, Grant},
title = {Assessing the test–retest repeatability of insulin resistance measures: Homeostasis model assessment 2 and oral glucose insulin sensitivity},
journal = {Journal of Metabolic Health},
year = {2017},
doi = {10.4102/jir.v2i1.27}
}
EUVIMED